For Industry
- At VRF, we believe every vitiligo patient deserves the chance to participate in life-changing clinical trials. For those who haven’t found success with common—and often off-label—treatments, cutting-edge research may offer the best hope. Unfortunately, complex processes and me...
- The VR Foundation has been a trusted source for independent patient recruitment in vitiligo clinical trials, offering unmatched access to a dynamic and diverse patient base. Here’s what sets us apart: Unparalleled Patient Access Over 120,000 patients visit our website annually...
FAQOther Questions
- What causes vitiligo?
The exact cause is a complex puzzle, but we know the foundation: It is pre-wired in your genes. Think of your genetics as a loaded spring, just waiting for a specific "trigger" ...
- What tests for vitiligo should be done?
Before starting vitiligo therapy, several tests may be recommended to ensure an accurate diagnosis and appropriate treatment plan: Physical Examination A thorough physical exami...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.